Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy

NCT04456517 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Low accrual and subject engagement

Conditions

Crohn's Disease
Inflammatory Bowel Disease

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center